Abstract
Diabetes and its complications are major causes of mortality in the United States, with increasing rates of morbidity and increasing health care costs. Patients diagnosed with diabetes attempt to control cholesterol levels, blood pressure, and blood glucose levels to decrease the risk of diabetic microvascular complications (DMC), such as diabetic sensorimotor polyneuropathy (DSP) [also known as diabetic peripheral neuropathy (DPN)]. Despite control of these risk factors for vascular disease, many patients still develop DSP. Research investigating diabetic neuropathy holds promise for specific treatment of diabetic complications. Intrinsic to the success of new therapies is the accurate diagnosis and evaluation of DSP. Symptom scores, quantitative sensory testing and electrophysiology are some of the diagnostic tools to identify the signs and symptoms of DSP. Early detection of neuropathy enables clinicians to prevent long-term complications like ulcers and amputations in patients with diabetes. The focus of this review is to describe the composite of tools necessary for diagnosis of DSP.
Keywords: Diabetic Sensorimotor Polyneuropathy (DPN), Vibration perception threshold (VPT), Diagnostic tools, diabetes, Quantitative sensory testing (QST), Diabetic microvascular complications
Current Diabetes Reviews
Title: Diagnostic Tools for Diabetic Sensorimotor Polyneuropathy
Volume: 2 Issue: 3
Author(s): Keri A. Kles and Vera Bril
Affiliation:
Keywords: Diabetic Sensorimotor Polyneuropathy (DPN), Vibration perception threshold (VPT), Diagnostic tools, diabetes, Quantitative sensory testing (QST), Diabetic microvascular complications
Abstract: Diabetes and its complications are major causes of mortality in the United States, with increasing rates of morbidity and increasing health care costs. Patients diagnosed with diabetes attempt to control cholesterol levels, blood pressure, and blood glucose levels to decrease the risk of diabetic microvascular complications (DMC), such as diabetic sensorimotor polyneuropathy (DSP) [also known as diabetic peripheral neuropathy (DPN)]. Despite control of these risk factors for vascular disease, many patients still develop DSP. Research investigating diabetic neuropathy holds promise for specific treatment of diabetic complications. Intrinsic to the success of new therapies is the accurate diagnosis and evaluation of DSP. Symptom scores, quantitative sensory testing and electrophysiology are some of the diagnostic tools to identify the signs and symptoms of DSP. Early detection of neuropathy enables clinicians to prevent long-term complications like ulcers and amputations in patients with diabetes. The focus of this review is to describe the composite of tools necessary for diagnosis of DSP.
Export Options
About this article
Cite this article as:
A. Kles Keri and Bril Vera, Diagnostic Tools for Diabetic Sensorimotor Polyneuropathy, Current Diabetes Reviews 2006; 2 (3) . https://dx.doi.org/10.2174/157339906777950598
DOI https://dx.doi.org/10.2174/157339906777950598 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inflammatory Markers Associated With Diabetes Mellitus – Old and New Players
Current Pharmaceutical Design Redefining the Role of Long-Acting Phosphodiesterase Inhibitor Tadalafil in the Treatment of Diabetic Erectile Dysfunction
Current Diabetes Reviews Editorial [Hot Topic: Management of Diabetes Mellitus: The Five Pillars of Wisdom (Guest Editors: C.D.A. Stehouwer, N.C. Schaper and M. Huijberts)]
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Molecular Genetics and Epidemiology of Japanese Type 1 Diabetes
Current Pharmacogenomics Vasoactive Renal Factors and the Progression of Diabetic Nephropathy
Current Pharmaceutical Design N-Aroylated Isatins: Antiglycation Activity
Letters in Drug Design & Discovery Oral Delivery of Insulin Loaded into Polymeric Nanoparticles in Rats
Drug Delivery Letters Depression and Quality of Life in Patients with Diabetes: A Systematic Review from the European Depression in Diabetes (EDID) Research Consortium
Current Diabetes Reviews Impact of Nutrition Transition and Resulting Morbidities on Economic and Human Development
Current Diabetes Reviews Trypanosomatid Parasites Causing Neglected Diseases
Current Medicinal Chemistry Metabotropic Glutamate Receptors (mGluRs) and Diabetic Neuropathy
Current Drug Targets Subject Index to Volume 10
Current Pharmaceutical Design Gallium in Cancer Treatment
Current Topics in Medicinal Chemistry Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic Review
Current Topics in Medicinal Chemistry The Secretin/Pituitary Adenylate Cyclase-Activating Polypeptide/ Vasoactive Intestinal Polypeptide Superfamily in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Antioxidant Capacities of Flavones and Benefits in Oxidative-Stress Related Diseases
Current Topics in Medicinal Chemistry Pathophysiology of Erectile Dysfunction
Current Drug Targets Treatment of Diabetic Cardiovascular Autonomic, Peripheral and Painful Neuropathy. Focus on the Treatment of Cardiovascular Autonomic Neuropathy with ACE Inhibitors
Current Vascular Pharmacology Current Antioxidant Molecular Therapies for Oxidative Stress-Related Ailments
Current Gene Therapy CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Current Pharmaceutical Design